rs139190144

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002435.3(MPI):​c.684C>T​(p.Asn228Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0281 in 1,614,080 control chromosomes in the GnomAD database, including 886 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 60 hom., cov: 32)
Exomes 𝑓: 0.029 ( 826 hom. )

Consequence

MPI
NM_002435.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.96

Publications

5 publications found
Variant links:
Genes affected
MPI (HGNC:7216): (mannose phosphate isomerase) Phosphomannose isomerase catalyzes the interconversion of fructose-6-phosphate and mannose-6-phosphate and plays a critical role in maintaining the supply of D-mannose derivatives, which are required for most glycosylation reactions. Mutations in the MPI gene were found in patients with carbohydrate-deficient glycoprotein syndrome, type Ib. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
MPI Gene-Disease associations (from GenCC):
  • MPI-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Myriad Women’s Health, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 15-74896165-C-T is Benign according to our data. Variant chr15-74896165-C-T is described in ClinVar as Benign. ClinVar VariationId is 167305.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.96 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0635 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MPINM_002435.3 linkc.684C>T p.Asn228Asn synonymous_variant Exon 6 of 8 ENST00000352410.9 NP_002426.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MPIENST00000352410.9 linkc.684C>T p.Asn228Asn synonymous_variant Exon 6 of 8 1 NM_002435.3 ENSP00000318318.6

Frequencies

GnomAD3 genomes
AF:
0.0213
AC:
3240
AN:
152140
Hom.:
60
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00490
Gnomad AMI
AF:
0.0844
Gnomad AMR
AF:
0.0141
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0689
Gnomad FIN
AF:
0.0395
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0281
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.0254
AC:
6388
AN:
251398
AF XY:
0.0287
show subpopulations
Gnomad AFR exome
AF:
0.00492
Gnomad AMR exome
AF:
0.00809
Gnomad ASJ exome
AF:
0.00804
Gnomad EAS exome
AF:
0.000217
Gnomad FIN exome
AF:
0.0352
Gnomad NFE exome
AF:
0.0268
Gnomad OTH exome
AF:
0.0213
GnomAD4 exome
AF:
0.0288
AC:
42143
AN:
1461822
Hom.:
826
Cov.:
31
AF XY:
0.0301
AC XY:
21902
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.00424
AC:
142
AN:
33480
American (AMR)
AF:
0.00941
AC:
421
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00650
AC:
170
AN:
26136
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39700
South Asian (SAS)
AF:
0.0665
AC:
5740
AN:
86258
European-Finnish (FIN)
AF:
0.0356
AC:
1902
AN:
53404
Middle Eastern (MID)
AF:
0.0252
AC:
145
AN:
5758
European-Non Finnish (NFE)
AF:
0.0289
AC:
32160
AN:
1111974
Other (OTH)
AF:
0.0241
AC:
1457
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
2361
4722
7082
9443
11804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1222
2444
3666
4888
6110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0213
AC:
3242
AN:
152258
Hom.:
60
Cov.:
32
AF XY:
0.0225
AC XY:
1677
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00488
AC:
203
AN:
41558
American (AMR)
AF:
0.0141
AC:
216
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.0696
AC:
336
AN:
4826
European-Finnish (FIN)
AF:
0.0395
AC:
419
AN:
10602
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0281
AC:
1911
AN:
68014
Other (OTH)
AF:
0.0189
AC:
40
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
162
324
487
649
811
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0227
Hom.:
36
Bravo
AF:
0.0175
Asia WGS
AF:
0.0170
AC:
59
AN:
3478
EpiCase
AF:
0.0293
EpiControl
AF:
0.0260

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 14, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 27, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

MPI-congenital disorder of glycosylation Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
15
DANN
Benign
0.78
PhyloP100
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139190144; hg19: chr15-75188506; COSMIC: COSV107396476; COSMIC: COSV107396476; API